StonvexLoading…
StonvexStonvexStonvexCore line items from ITW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.02B | $16.04B | $11.95B | $7.89B |
Operating Income | $1.02B | $4.22B | $3.13B | $2.02B |
Net Income | $768.00M | $3.07B | $2.28B | $1.46B |
EPS (Diluted) | $2.66 | $10.49 | $7.77 | $4.95 |
Total Assets | $16.26B | $16.15B | $16.14B | $16.05B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $827.00M | $851.00M | $924.00M | $788.00M |
Free Cash Flow OCF − CapEx | $528.00M | $2.71B | $1.85B | $945.00M |
Shares Outstanding | 287.70M | 288.60M | 290.10M | 291.50M |